Nektar Therapeutics (NASDAQ:NKTR)

86.21
Delayed Data
As of Apr 20
 -3.94 / -4.37%
Today’s Change
17.33
Today|||52-Week Range
111.36
+44.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues200.7M230.8M165.4M307.7M
 
 
 
 
 
Cost of Goods Sold22.2M27.8M22.8M22.8M
 
 
 
 
 
Depreciation And Amortization12.9M12.9M15.4M14.7M
 
 
 
 
 
 
Operating ExpensesGross Income165.5M190.2M127.3M270.2M
 
 
 
 
 
General Expenses182.0M216.5M240.1M309.2M
 
 
 
 
 
Research And Development141.1M176.3M195.9M260.1M
 
 
 
 
 
Total Operating Expenses217.2M257.2M278.3M346.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.5M-26.4M-112.9M-39.0M
 
 
 
 
 
Extraordinary Charge0.00-17.1M0.00-20.7M
 
 
 
Interest Expense On Debt38.8M38.9M42.2M41.0M
 
 
 
 
 
Other Expenses814.0K1.7M2.4M4.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-54.4M-80.7M-152.6M-96.1M
 
 
 
 
 
Income Taxes-512.0K-506.0K-876.0K-616.0K
 
 
 
 
 
Net Income-53.9M-81.2M-153.5M-96.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS126.9M132.5M139.6M156.0M
 
 
 
 
 
Shares To Calculate EPS Diluted126.9M132.5M139.6M156.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.42-$0.61-$1.10-$0.62
 
 
 
 
 
EPS Diluted-$0.42-$0.61-$1.10-$0.62